4.8 Article

Three-Component Pd/Cu-Catalyzed Cascade Reactions of Cyclic Iodoniums, Alkynes, and Boronic Acids: An Approach to Methylidenefluorenes

期刊

ORGANIC LETTERS
卷 16, 期 9, 页码 2350-2353

出版社

AMER CHEMICAL SOC
DOI: 10.1021/ol5006714

关键词

-

资金

  1. Doctoral Program of Higher Education of China [20110171120098]
  2. National Basic Research Program of China (973 Program) [2012CB967004]

向作者/读者索取更多资源

Linear diaryliodonium salts are widely used as arylating reagents for C-C and C-X bond formation. Meanwhile, synthetic applications of cyclic iodoniums are relatively rare although they offer the opportunity to set up reaction cascades. We demonstrate an atom and step economical three-component reaction involving cyclic diphenyleneiodoniums, alkynes, and boronic acids, resulting in the construction of methylidenefluorenes in a single operation. Our route enables facile access to both symmetrical and unsymmetrical methylidenefluorene derivatives, compounds that have attracted interest due to their optical properties.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Pharmacology & Pharmacy

PT109, a novel multi-kinase inhibitor suppresses glioblastoma multiforme through cell reprogramming: Involvement of PTBP1/PKM1/2 pathway

Yang Yang, Yalin Tu, Junfeng Lu, Qiuhe Chen, Zeyu Zhu, Weijia Peng, Wenbo Zhu, Shijun Wen, Ji Zhang, Wei Yin, Rongbiao Pi

Summary: This study discovered a novel multi-kinase inhibitor, PT109, which suppressed the proliferation, colony formation, and migration of GBM cells, and reprogrammed them into oligodendrocytes. Proteomic analysis showed that PT109 influenced energy metabolism, cell cycle, and immune system processes of GBM-associated proteins. Metabolomic analysis revealed that PT109 improved the aerobic respiration process in glioma cells. Overall, PT109 provided a new strategy for the development of anti-glioma drugs by reprogramming GBM and changing its metabolic pattern through the PTBP1/PKM1/2 pathway.

EUROPEAN JOURNAL OF PHARMACOLOGY (2022)

Article Chemistry, Medicinal

Identification of the Benzoimidazole Compound as a Selective FLT3 Inhibitor by Cell-Based High-Throughput Screening of a Diversity Library

Tian Tian, Shengyi Zhang, Bingling Luo, Feng Yin, Wenhua Lu, Yiqing Li, Kezhi Huang, Qiao Liu, Peng Huang, G. Garcia-Manero, Shijun Wen, Yumin Hu

Summary: In this study, a benzoimidazole compound was identified as a selective treatment for FLT3/ITD leukemia. The compound HP1328, derived from the benzoimidazole scaffold, demonstrated desirable properties and significantly reduced leukemia burden and prolonged survival in mice.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Biochemistry & Molecular Biology

Synthesis of [1-8-NαC]-zanriorb A1, alanine-containing analogues, and their cytotoxic and anti-inflammatory activity

Muhammad Nadeem-ul-Haque, Anila Bashir, Humira Karim, Sadiq Noor Khan, Zafar Ali Shah, Almas Jabeen, Shaista Qayyum, A. Ganesan, M. Iqbal Choudhary, Farzana Shaheen

Summary: This study investigated the synthesis of [1-8-N alpha C]-zanriorb A1 from the medicinal plant Zanthoxylum riedelianum. The solution-phase route produced a mixture of proline rotamers, while the on-resin cyclization was less successful. Analogues of zanriorb A1 were also synthesized, and one compound showed strong anti-inflammatory potential.

JOURNAL OF PEPTIDE SCIENCE (2022)

Article Chemistry, Organic

Tandem cyclization/arylation of diaryliodoniums via in situ constructed benzoxazole as a directing group for atom-economical transformation

Hui Peng, Qian Liu, Yameng Sun, Bingling Luo, Tianyian Yu, Peng Huang, Daqian Zhu, Shijun Wen

Summary: In this study, it was demonstrated that linear unsymmetrical diaryliodoniums can undergo one-pot cyclization/arylation using a dual nickel/palladium metal system, and the in situ generated benzoxazole motifs can be utilized as directing groups for subsequent C-H activated arylation from the unwanted aryl iodide, exhibiting good atom economy and regioselectivity.

ORGANIC CHEMISTRY FRONTIERS (2022)

Article Chemistry, Multidisciplinary

Euglenatides, Potent Antiproliferative Cyclic Peptides Isolated from the Freshwater Photosynthetic Microalga Euglena gracilis

Mohammed Aldholmi, Rizwan Ahmad, Daniel Carretero-Molina, Ignacio Perez-Victoria, Jesus Martin, Fernando Reyes, Olga Genilloud, Lea Gourbeyre, Thierry Gefflaut, Hanne Carlsson, Alexei Maklakov, Ellis O'Neill, Robert A. Field, Barrie Wilkinson, Maria O'Connell, A. Ganesan

Summary: The study discovered that euglenatides from Euglena gracilis can inhibit pathogenic fungi and cancer cells, and bear resemblance to nemamides in Caenorhabditis elegans. Molecular network analysis also revealed the presence of multiple euglenatide-like metabolites in Euglena species.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2022)

Article Oncology

Reductive TCA cycle catalyzed by wild-type IDH2 promotes acute myeloid leukemia and is a metabolic vulnerability for potential targeted therapy

Peiting Zeng, Wenhua Lu, Jingyu Tian, Shuang Qiao, Jiangjiang Li, Christophe Glorieux, Shijun Wen, Hui Zhang, Yiqing Li, Peng Huang

Summary: The study found that overexpressed wild-type IDH2 in AML promoted leukemia cell survival and proliferation by facilitating the conversion of alpha-KG to isocitrate/citrate for lipid synthesis. Inhibition of wild-type IDH2 resulted in reduced lipid synthesis, decreased c-Myc expression downregulated by alpha-KG, and inhibition of AML viability and proliferation. Pharmacological inhibition of IDH2 showed therapeutic effects in AML cells with wild-type IDH2, inducing downregulation of C-MYC in vivo.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2022)

Article Chemistry, Medicinal

Design and Synthesis of Dual EZH2/BRD4 Inhibitors to Target Solid Tumors

Zhirong Guo, Yameng Sun, Liyun Liang, Wenhua Lu, Bingling Luo, Zhouming Wu, Bitao Huo, Yumin Hu, Peng Huang, Qiang Wu, Shijun Wen

Summary: This study presents the design, synthesis, and biological evaluation of first-in-class dual EZH2/BRD4 inhibitors. The most promising compound, YM458, demonstrates potent inhibitory activity against EZH2 and BRD4 and remarkable antiproliferative capacity against various solid cancer cell lines. In vivo experiments validate the therapeutic potential of EZH2/BRD4 dual inhibitors in lung cancer and pancreatic cancer xenograft tumor models, highlighting their potential to target a broad scope of resistant solid tumors.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Chemistry, Multidisciplinary

A Temporal PROTAC Cocktail-Mediated Sequential Degradation of AURKA Abrogates Acute Myeloid Leukemia Stem Cells

Fang Liu, Xuan Wang, Jianli Duan, Zhijie Hou, Zhouming Wu, Lingling Liu, Hanqi Lei, Dan Huang, Yifei Ren, Yue Wang, Xinyan Li, Junxiao Zhuo, Zijian Zhang, Bin He, Min Yan, Huiming Yuan, Lihua Zhang, Jinsong Yan, Shijun Wen, Zifeng Wang, Quentin Liu

Summary: This study introduces a PROTAC cocktail that effectively degrades AURKA in acute myeloid leukemia cells, inhibits AML stem cells, and induces AML regression in mouse models and primary patient cells. This spatial-temporal drug administration strategy shows promise in eliminating the multifaceted functions of oncoproteins and preventing cancer stem cell-mediated drug resistance.

ADVANCED SCIENCE (2022)

Article Biochemistry & Molecular Biology

Developing Bi-Gold Compound BGC2a to Target Mitochondria for the Elimination of Cancer Cells

Qingbin Cui, Wenwen Ding, Panpan Liu, Bingling Luo, Jing Yang, Wenhua Lu, Yumin Hu, Peng Huang, Shijun Wen

Summary: This study demonstrates that enhancing the mitochondria-targeting capacity of gold compounds can enhance their efficacy in eradicating cancer cells. Bi-gold compounds showed better suppression of cancer cell proliferation compared to mono-gold compounds, and the most potent compound, BGC2a, inhibited the antioxidant enzyme TrxR and increased cellular ROS. BGC2a accumulated within mitochondria, leading to mitochondrial dysfunction and inhibition of tumor growth.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Review Chemistry, Multidisciplinary

Recent Progress in Cyclic Aryliodonium Chemistry: Syntheses and Applications

Xiaopeng Peng, Abdur Rahim, Weijie Peng, Feng Jiang, Zhenhua Gu, Shijun Wen

Summary: This article summarizes the recent advances in the research field of cyclic aryliodoniums, including their design and synthetic applications. The general preparation of typical diphenyl iodoniums, construction of heterocyclic iodoniums and monoaryl iodoniums are described. The use of cyclic aryliodoniums as initiators for cascade reactions and the construction of complex structures such as polycycles and biaryls are discussed. Furthermore, the recent advance of cyclic aryliodoniums as halogen-bonding organocatalysts is described.

CHEMICAL REVIEWS (2023)

Article Oncology

Dual LSD1 and HDAC6 Inhibition Induces Doxorubicin Sensitivity in Acute Myeloid Leukemia Cells

Ipek Bulut, Adam Lee, Buse Cevatemre, Dusan Ruzic, Roman Belle, Akane Kawamura, Sheraz Gul, Katarina Nikolic, A. Ganesan, Ceyda Acilan

Summary: The newly developed LSD1/HDAC6 dual inhibitor iDual can inhibit the growth of leukemia cells by simultaneously targeting HDAC6 and LSD1, and it can enhance drug-induced apoptosis when used in combination with doxorubicin.

CANCERS (2022)

Article Pharmacology & Pharmacy

Discovery of 1-Benzhydryl-Piperazine-Based HDAC Inhibitors with Anti-Breast Cancer Activity: Synthesis, Molecular Modeling, In Vitro and In Vivo Biological Evaluation

Dusan Ruzic, Bernhard Ellinger, Nemanja Djokovic, Juan F. Santibanez, Sheraz Gul, Milan Beljkas, Ana Djuric, Arasu Ganesan, Aleksandar Pavic, Tatjana Srdic-Rajic, Milos Petkovic, Katarina Nikolic

Summary: This report describes the design and discovery of two selective HDAC6 inhibitors and two non-selective HDAC inhibitors. Molecular modeling found that the linker chemistry of the inhibitors influences their potency. A novel non-selective HDAC inhibitor with a longer linker showed potent anti-tumor, anti-metastatic, and anti-angiogenic effects.

PHARMACEUTICS (2022)

Article Plant Sciences

Design and synthesis of peptide-drug conjugates to double target EGFR

Xiaozhuo Tan, Meiling Le, Haiwen Wang, Bitao Huo, Tiantian Yu, Peng Huang, Tiangang Luan, Shijun Wen

Summary: This study reports the design and synthesis of novel peptide-drug conjugates (PDCs) that bind to both the extracellular and intracellular domains of epidermal growth factor receptor (EGFR). One peptide motif interacts with the extracellular domain, while the other motif derived from an EGFR inhibitor occupies the intracellular kinase domain. Among the synthetic PDCs, compound 14c shows the best inhibition of EGFR phosphorylation and the ability to inhibit cell proliferation and colony formation in lung cancer cells. This study provides a novel strategy to develop more potent EGFR inhibitors by targeting both extracellular and intracellular domains simultaneously.

PHYTOCHEMISTRY LETTERS (2023)

Article Microbiology

Synthesis of Altissimacoumarin D and Other Prenylated Coumarins and Their Ability to Reverse the Multidrug Resistance Phenotype in Candida albicans

Anna Claudia Silva, Daniel Clemente de Moraes, Denilson Costa do Carmo, Giselle Cristina Casaes Gomes, A. Ganesan, Rosangela Sabbatini Capella Lopes, Antonio Ferreira-Pereira, Claudio Cerqueira Lopes

Summary: Azoles are the main antifungal drugs used to treat invasive candidiasis, but their efficacy is limited by fungal resistance mechanisms like overexpression of efflux pumps. A potential strategy to overcome this resistance is to inhibit the efflux process. This study aimed to synthesize altissimacoumarin D and its analogues to evaluate their ability to reverse the resistance phenotype of Candida albicans.

JOURNAL OF FUNGI (2023)

Article Chemistry, Organic

Growth vector elaboration of fragments: regioselective functionalization of 5-hydroxy-6-azaindazole and 3-hydroxy-2,6-naphthyridine

Paulo Eliandro da Silva Junior, Shaiani Maria Gil de Melo, Murilo Helder de Paula, Ricardo Vessecchi, Till Opatz, James E. H. Day, A. Ganesan, Flavio da Silva Emery

Summary: This article discusses the reactivity of 6-azaindazole and 2,6-naphthyridine, which are important in fragment-based drug discovery. The article introduces selective functionalization methods for pyridone and pyrazole, as well as a new method for selective functionalization of heterocycle 1.

ORGANIC & BIOMOLECULAR CHEMISTRY (2022)

暂无数据